ByHeart tests find botulism bacteria; all lots may be contaminated

📌 Key Facts

ByHeart reported that 5 of 36 product samples from three lots tested positive for Clostridium botulinum type A and said it “cannot rule out” contamination across all lots.
At least 31 infants in 15 states have been sickened since August; some ByHeart-fed infants were treated as far back as November 2024 (not counted in the outbreak tally).
At least 107 infants nationwide have received BabyBIG antitoxin treatment since Aug. 1.
A typical year sees fewer than 200 infant botulism cases nationwide, underscoring the scale of recent treatments and illnesses.
Despite a nationwide recall issued Nov. 11, FDA and state officials reported that some ByHeart product remained on store shelves.
ByHeart expanded its refund policy: customers who bought product on the company’s website on or after Aug. 1 can receive a full refund.

On X, parents share personal stories of their infants' symptoms like vomiting and hospitalization after consuming ByHeart formula, emphasizing the emotional distress and calls for community prayers, which mainstream media often overlooks in favor of factual outbreak updates.
Users on X frequently compare the ByHeart recall to the 2022 Abbott Nutrition crisis, highlighting patterns of regulatory delays and repeated bacterial contaminations in the infant formula industry, a historical context missing from current mainstream coverage.
X posts discuss ongoing lawsuits by affected families against ByHeart, including details about severe cases like airlifted infants, adding a legal and accountability perspective not deeply explored in mainstream articles.
Social media users express frustration over the recall's timing, noting that some infants showed botulism symptoms months before the official announcement, pointing to potential delays in detection that mainstream reports mention but do not delve into from a parental viewpoint.
Discussions on X include concerns about trust in organic or premium baby formula brands like ByHeart, with users debating the safety of 'whole nutrition' products and sharing experiences of switching brands, a consumer sentiment angle absent in mainstream coverage.

Based on 2 sources

Twin Cities by Associated Press November 25, 2025

New information:

ByHeart reported 5 of 36 product samples from three lots tested positive for Clostridium botulinum type A and said it 'cannot rule out' contamination across all lots.
Outbreak status: at least 31 infants in 15 states have been sickened since August; some ByHeart-fed infants were treated as far back as Nov. 2024 (not counted in the outbreak).
Despite the Nov. 11 nationwide recall, some product remained on store shelves, according to FDA and state officials.
At least 107 infants nationwide have received BabyBIG treatment since Aug. 1; a typical year sees fewer than 200 infant botulism cases.
Refund policy expanded: customers who bought on ByHeart’s website on or after Aug. 1 can receive a full refund.

Twin Cities by Associated Press November 11, 2025